Publication Highlights
Our team has contributed to the following publications
The CanCOLD Study
2023
Factors associated with attrition in a longitudinal cohort of older adults in the community
Physical activity and symptom burden in COPD: the Canadian Obstructive Lung Disease study
Impaired spirometry and chronic obstructive pulmonary disease increase the risk of cardiovascular disease: a Canadian cohort study
2022
Ambient air pollution and dysanapsis: associations with lung function and chronic obstructive pulmonary disease in the Canadian Cohort Obstructive Lung Disease Study
Impaired ventilatory efficiency, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease: results from the CanCOLD study
2021
Dyspnoea and symptom burden in mild-moderate COPD: the Canadian Cohort Obstructive Lung Disease study
The prevalence of chronic obstructive pulmonary disease (COPD) and the heterogeneity of risk factors in the Canadian population: results from the Canadian Obstructive Lung Disease (COLD) study
High eosinophil counts predict decline in FEV1: results from the CanCOLD study
2020
Identification and definition of asthma-COPD overlap: the CanCOLD study
2019
The effects of marijuana smoking on lung function in older people
Impaired sleep quality in COPD is associated with exacerbations: the CanCOLD cohort study
Physiological distress is related to poor health behaviours in COPD and non-COPD patients: evidence from the CanCOLD study
2018
Global initiative for chronic obstructive lung disease 2017 classification and lung function decline in chronic obstructive pulmonary disease
Total airway count on computed tomography and the risk of chronic obstructive pulmonary disease progression. Findings from a population-based study
2017
Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study
2016
The COPD assessment test: can it discriminate across COPD subpopulations?
Findings on thoracic computed tomography scans and respiratory outcomes in persons with and without chronic obstructive pulmonary disease: a population-based cohort study
Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD study
Undiagnosed COPD and Asthma Population (UCAP) Study
2023
Assessment of Preserved Ratio Impaired Spirometry Using Pre- and Post-Bronchodilator Spirometry in a Randomly Sampled Symptomatic Cohort
Patient and physician factors associated with symptomatic undiagnosed asthma or COPD
Impact of Undiagnosed Chronic Obstructive Pulmonary Disease and Asthma on Symptoms, Quality of Life, Healthcare Use, and Work Productivity
2022
Disease burden in individuals with symptomatic undiagnosed asthma or COPD
Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPD
2020
Population-based case-finding to identify subjects with undiagnosed asthma or COPD
DESTINATION
2023
Long-term safety and efficacy of Tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
NAVIGATOR
2021
Tezepelumab in adults and adolescents with severe, uncontrolled asthma
2020
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of Tezepelumab in adults and adolescents with severe, uncontrolled asthma
CASCADE
2020
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
SABA use IN Asthma (SABINA) Study
2023
Beware SABA Overuse: a Message from the Global SABINA Program
2022
Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
ANDHI
2021
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patient with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
The Asthma Diagnosis Study
2020
Performance characteristics of spirometry with negative bronchodilator response and methacholine challenge testing and implications for asthma diagnosis
2017
Reevaluation of diagnosis in adults with physician-diagnosed asthma
2016
Establishing a correct diagnosis in adults who have been mis-diagnosed with asthma
COPD Transition Bundle Intervention
2023
Cost analysis of a transition care bundle compared with usual care for COPD patients being discharged from hospital: evaluation of a randomized control trial
2022
Optimizing COPD acute care patient outcomes using a standardized transition bundle and care coordinator: a randomized clinical trial
2020
Factors influencing the implementation and uptake of a discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease: a qualitative focus group study
Other
2023
Canadian multidisciplinary expert consensus on the use of biologics in upper airways: a Delphi study
Medication use of Canadians with chronic obstructive pulmonary disease: a cohort study
Effectiveness of Benralizumab after 12 months of treatment in Canadians with Severe Asthma
A population-based study of the burden of severe asthma in Alberta, Canada
The risk of exacerbation with elevated biomarkers, and real-world biomarker variability, in patients with severe asthma: a retrospective, population-based study
2023 Canadian Thoracic Society guideline on pharmacotherapy in patients with stable COPD
Canadian health care professionals' familiarity with chronic cough guidelines and experiences with diagnosis and management: a cross-sectional survey
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma
Sounding the alarmins - the role of alarmin cytokines in asthma
2022
Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel
Effects of traffic-related air pollution on exercise endurance, dyspnea, and cardiorespiratory responses in health and COPD: a randomized, placebo-controlled, crossover trial
Long-term modulation of airway remodeling in severe asthma following bronchial thermoplasty
2021
Transcriptome-level interactions between budesonide and formoterol provide insight into the mechanism of action of inhaled corticosteroid/long-acting β2-adrenoceptor agonist combination therapy in asthma